RESPIRATORY RESEARCH
Scope & Guideline
Leading the Charge in Respiratory Health Advancements
Introduction
Aims and Scopes
- Clinical Research in Respiratory Diseases:
The journal emphasizes clinical studies that explore the diagnosis, treatment, and management of various respiratory conditions such as asthma, COPD, pulmonary fibrosis, and lung cancer. - Molecular and Cellular Mechanisms:
Research articles often delve into the molecular and cellular basis of respiratory diseases, including studies on signaling pathways, gene expression, and cellular responses to environmental factors. - Impact of Environmental Factors:
The journal publishes studies examining how environmental factors, such as air pollution and smoking, affect respiratory health, and the underlying mechanisms involved. - Innovative Therapeutic Approaches:
There is a strong focus on novel therapeutic strategies, including pharmacological interventions, biologics, and advanced therapies like stem cell applications in respiratory diseases. - Epidemiological Studies and Public Health:
The journal includes epidemiological research that provides insights into the prevalence, risk factors, and outcomes related to respiratory diseases at both local and global levels. - Technological Advancements in Respiratory Care:
Research on the development and application of new technologies, such as machine learning and imaging techniques, for the diagnosis and treatment of respiratory conditions is a key area of interest.
Trending and Emerging
- Machine Learning and Artificial Intelligence Applications:
There is a rising trend in the application of machine learning and AI in diagnosing and managing respiratory diseases, showcasing the potential for enhanced predictive modeling and patient stratification. - Long COVID Research:
Emerging studies focusing on the long-term respiratory effects of COVID-19 highlight the need for understanding this new cohort of patients and the management of post-viral respiratory complications. - Microbiome and Respiratory Health:
Research into the role of the microbiome in respiratory health and disease is gaining momentum, with studies exploring how microbial communities influence conditions like asthma and COPD. - Personalized Medicine and Biomarkers:
There is a significant focus on personalized medicine approaches, including the identification of biomarkers for disease progression and treatment response, particularly in chronic respiratory diseases. - Environmental Impact on Respiratory Diseases:
Increased attention is being given to how environmental factors, including climate change and pollution, contribute to respiratory diseases, driving research that links public health with environmental science.
Declining or Waning
- Traditional Pharmacotherapy for Asthma and COPD:
There has been a noticeable decrease in studies focusing solely on traditional pharmacological treatments for asthma and COPD, as newer biologic therapies and personalized medicine approaches gain traction. - Basic Science without Clinical Relevance:
Research that does not translate into clinical applications or patient outcomes is becoming less favored, as the journal prioritizes studies that directly impact patient care. - Cohort Studies with Limited Novel Insights:
Cohort studies that fail to provide new insights or that replicate existing knowledge without adding significant value have seen a reduction in publication rates. - Animal Models with Limited Human Relevance:
There has been a decline in studies using animal models that do not sufficiently bridge the gap to human physiology or that do not contribute to understanding clinical phenomena.
Similar Journals
Respiratory Investigation
Exploring the depths of pulmonary innovations.Respiratory Investigation is a leading peer-reviewed journal published by Elsevier, dedicated to advancing the field of Pulmonary and Respiratory Medicine. Since its inception in 2012, the journal has grown to become a vital resource for researchers, clinicians, and students alike, providing a platform for high-quality research articles, reviews, and clinical studies. With a commendable impact factor and ranked in the Q2 category of Scopus' 2023 metrics, it stands at rank #57 out of 155 in its field, illustrating its importance and influence within the academic community. Although the journal operates on a subscription basis, it remains committed to disseminating essential findings that enhance the understanding and treatment of respiratory diseases. Set against the innovative backdrop of the Netherlands, Respiratory Investigation not only serves as a conduit for scholarly exchange but also plays a critical role in shaping future research directions and clinical practices.
LUNG
Pioneering insights in respiratory health and clinical practice.LUNG is a prestigious academic journal that has been a cornerstone in the field of Pulmonary and Respiratory Medicine since its inception in 1959. Published by SPRINGER, the journal holds an impressive Q1 ranking in its category for 2023, reflecting its commitment to disseminating high-quality research and advancing clinical practices in respiratory health. With a Scopus rank of 24 out of 155 in its field, representing the top 16% of journals, LUNG continues to serve as a vital platform for researchers, clinicians, and students who are dedicated to addressing the complexities of lung diseases. Although currently not an open-access journal, LUNG offers valuable insights and significant contributions to the understanding of respiratory conditions, ensuring that its readership stays at the forefront of medical advancements. Researchers and professionals are encouraged to submit their work and engage with a thriving academic community that is passionate about improving patient outcomes in pulmonary health.
BMJ Open Respiratory Research
Elevating global discourse in pulmonary and respiratory research.BMJ Open Respiratory Research is a prestigious open access journal published by the BMJ Publishing Group, dedicated to advancing the field of pulmonary and respiratory medicine. Since its inception in 2014, the journal has provided a vital platform for the dissemination of innovative research and clinical findings, boasting an impressive Q1 ranking in its category as of 2023. With a Scopus rank of #35 out of 155 in Pulmonary and Respiratory Medicine, BMJ Open Respiratory Research is recognized for its high-quality content, engaging a global audience of researchers, healthcare professionals, and students. The journal embraces an open access model, ensuring that groundbreaking research is readily available to the community and stakeholders, thereby accelerating knowledge exchange and improving patient care. By focusing on diverse aspects of respiratory health, this journal plays a crucial role in shaping the future of respiratory research and practice.
Turkish Thoracic Journal
Fostering collaboration in the pursuit of respiratory excellence.Turkish Thoracic Journal, published by AVES, is a prominent open-access platform dedicated to advancing the field of pulmonary and respiratory medicine. Since its establishment, the journal has aimed to disseminate significant research findings, clinical studies, and reviews that contribute to an improved understanding of respiratory health challenges, with a particular focus on the Turkish context and regional issues. With an E-ISSN of 2149-2530 and transitioning to open access in 2022, the journal enhances visibility and accessibility, inviting a global audience of researchers, clinicians, and students to engage with the latest scientific work. The Turkish Thoracic Journal has been indexed in major databases, although it faced a coverage discontinuation in Scopus between 2016 and 2022. Currently positioned within the 23rd percentile among its peers in the field, it invites submissions that explore innovative approaches to thoracic health, enriching the discourse in a vital area of medicine.
REVUE DES MALADIES RESPIRATOIRES
Bridging research and practice in pulmonary medicine.REVUE DES MALADIES RESPIRATOIRES is a distinguished journal published by MASSON EDITEUR, focusing on the vital field of pulmonary and respiratory medicine. Established in 1984, this journal has become a prominent platform for sharing innovative research and clinical findings, reflecting an impressive array of studies that contribute to our understanding of respiratory diseases. With its ISSN 0761-8425 and E-ISSN 1776-2588, it facilitates access to scholarly work within the medical community, although it currently operates under a subscription model rather than Open Access. As indicated by its quartile ranking of Q4 in 2023 within its category and a Scopus rank of #128/155, REVUE DES MALADIES RESPIRATOIRES serves as an essential resource for researchers, professionals, and students aiming to stay informed about advancements in respiratory health. This journal plays a crucial role in fostering discussions that drive innovation and best practices in the treatment and understanding of respiratory conditions.
EUROPEAN RESPIRATORY JOURNAL
Pioneering Research for Better BreathingThe EUROPEAN RESPIRATORY JOURNAL, published by EUROPEAN RESPIRATORY SOC JOURNALS LTD, is at the forefront of advancing knowledge in the fields of pulmonary and respiratory medicine. With its ISSN 0903-1936 and E-ISSN 1399-3003, this esteemed journal has established itself as a leading platform since its inception in 1988, currently converging towards 2024. Ranked in the Q1 category for both Medicine (miscellaneous) and Pulmonary and Respiratory Medicine in 2023, it stands as the 3rd of 155 journals in its field, reflecting an impressive 98th percentile Scopus ranking. The journal boasts a rigorous selection of peer-reviewed articles that encompass innovative research, clinical studies, and reviews, thereby enhancing the understanding and treatment of respiratory diseases. Although it does not currently offer an Open Access option, the journal remains crucial for researchers, clinicians, and healthcare professionals committed to improving respiratory health across Europe and beyond. Join a community dedicated to groundbreaking research and advancements in respiratory medicine.
RESPIROLOGY
Championing Collaborative Research in RespirologyRESPIROLOGY is a prestigious academic journal that focuses on the field of Pulmonary and Respiratory Medicine, publishing high-quality research and comprehensive reviews that contribute significantly to the understanding and management of respiratory health. As a distinguished publication of WILEY, it has established a strong presence in the academic world with an impressive impact factor and ranked in the Q1 category, recognized for its influence and innovation in the field. RESPIROLOGY is committed to disseminating cutting-edge research from 1996 through 2024, appearing regularly in SCOPUS with a rank of #14 out of 155, placing it in the rarefied 91st percentile among its peers. The journal invites contributions from researchers, professionals, and students, fostering a collaborative space for advancing knowledge in pulmonary medicine. Although it does not offer open access, its readership spans globally, indicating the high regard in which it is held within the scientific community.
Lancet Respiratory Medicine
Innovating treatment strategies for respiratory diseases.The Lancet Respiratory Medicine, published by Elsevier in the United Kingdom, is a premier journal dedicated to the field of pulmonary and respiratory medicine. With its impressive impact factor and a prestigious ranking of #1 out of 155 in its category as of 2023, it holds a remarkable position in advancing research and clinical practices in respiratory health. The journal invites original research, reviews, and clinical studies that aim to propel the understanding of respiratory diseases, fostering innovations in treatment and management strategies. Operating under a Q1 category in Scopus rankings, it is an essential platform for researchers, healthcare professionals, and students who are committed to enhancing patient care and advancing knowledge in this crucial area of medicine. The Lancet Respiratory Medicine remains a vital resource for the latest findings and discussions shaping the future of respiratory health.
Tuberkuloz ve Toraks-Tuberculosis and Thorax
Exploring critical insights in thoracic medicine.Tuberkuloz ve Toraks (Tuberculosis and Thorax) is a distinguished journal published by the TURKISH ASSOCIATION OF TUBERCULOSIS AND THORAX located in Turkey. Serving as a pivotal platform for researchers and practitioners in the fields of Critical Care, Intensive Care Medicine, and Pulmonary and Respiratory Medicine, this journal has been disseminating vital research since 2003 and is committed to advancing knowledge and clinical practices related to tuberculosis and thoracic diseases. Although currently not an Open Access publication, its relevance is underscored by its rankings within Scopus, including a Q3 category in Critical Care and Intensive Care Medicine and a Q4 in Pulmonary and Respiratory Medicine, reflecting its significant contributions to the academic community. With a mission to foster the exchange of innovative ideas and encourage rigorous scholarly discourse, Tuberkuloz ve Toraks plays an essential role in addressing pressing health challenges associated with respiratory ailments and remains an invaluable resource for researchers, health professionals, and students dedicated to improving outcomes in thoracic health.
Zeitschrift fur Pneumologie
Catalyzing Change in Pulmonary Health ResearchZeitschrift für Pneumologie is a pivotal journal in the field of Pulmonary and Respiratory Medicine, published by Springer Heidelberg, a renowned name in academic publishing. With its ISSN number 2731-7404, it serves as a vital platform for disseminating innovative research and clinical studies relevant to lung health and diseases. This German-based journal aims to bridge the gap between research and practice, encouraging submissions that advance knowledge in respiratory medicine, including pathophysiology, treatment modalities, and patient care strategies. Although currently categorized in the Q4 quartile within its field, its commitment to quality research and emerging insights positions it as an essential resource for researchers, healthcare professionals, and students dedicated to improving respiratory health. The journal operates within the convergence period from 2022 to 2024, promising a dynamic evolution of its content. With limited open access availability, it encourages readership and contribution from its audience, fostering a collaborative academic environment.